Star Cement Limited has informed the Exchange regarding Board meeting held on May 21, 2025.
STARCEMENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 3.0 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Star Cement Limited's board, at its May 21, 2025 meeting, approved the audited standalone and consolidated financial results for Q4 and FY25, with statutory auditors M/s Singhi & Co. issuing an unmodified opinion. On a standalone basis, FY25 revenue from operations fell sharply to ₹1,99,218.89 lakhs (from ₹2,89,369.13 lakhs in FY24), and the company swung to a net loss of ₹15,846.50 lakhs versus a profit of ₹22,069.79 lakhs last year, with EPS at ₹(1.45) vs ₹5.46. Q4 FY25 however showed recovery, with standalone revenue rising to ₹65,825.84 lakhs (vs ₹45,115.99 lakhs) and a profit of ₹3,684.73 lakhs. On a consolidated basis, revenue grew to ₹3,16,339.49 lakhs (from ₹2,91,066.71 lakhs) but profit fell to ₹16,882.26 lakhs (from ₹29,511.03 lakhs). The standalone loss was driven by depreciation and finance costs rising sharply after the commissioning of the 3.3 MTPA Clinkerisation plant at Lumshnong in April 2024, with non-current borrowings jumping from ₹5,618 lakhs to ₹38,181 lakhs.
The FY25 standalone loss is a negative signal for shareholders, but the strong Q4 recovery and consolidated profitability suggest the pain was largely from new capacity ramp-up costs. Higher debt and interest burden remain key risks to watch in the coming quarters.